Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. UNH
stocks logo

UNH

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
113.44B
+12.53%
2.079
-69.47%
113.61B
+3.68%
6.626
-7.97%
113.51B
+1.7%
4.383
+7.42%
Estimates Revision
The market is revising Downward the revenue expectations for UnitedHealth Group Incorporated (UNH) for FY2025, with the revenue forecasts being adjusted by -0.16% over the past three months. During the same period, the stock price has changed by 29.62%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.16%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.35%
In Past 3 Month
Stock Price
Go Up
up Image
+29.62%
In Past 3 Month
Wall Street analysts forecast UNH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UNH is 386.27 USD with a low forecast of 198.00 USD and a high forecast of 440.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
22 Analyst Rating
Wall Street analysts forecast UNH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UNH is 386.27 USD with a low forecast of 198.00 USD and a high forecast of 440.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Buy
3 Hold
2 Sell
Moderate Buy
Current: 339.060
sliders
Low
198.00
Averages
386.27
High
440.00
Current: 339.060
sliders
Low
198.00
Averages
386.27
High
440.00
TD Cowen
Hold
maintain
$335 -> $338
2025-10-30
Reason
TD Cowen
Price Target
$335 -> $338
2025-10-30
maintain
Hold
Reason
TD Cowen raised the firm's price target on UnitedHealth to $338 from $335 and keeps a Hold rating on the shares. The firm updated its model as Q3 results checked a lot of boxes; adjusted EPS beat, FY25 guide raise, tax rate/investment income inline. They raise the target but keep the P/E target unchanged.
Bernstein
Lance Wilkes
Outperform
maintain
$433 -> $440
2025-10-30
Reason
Bernstein
Lance Wilkes
Price Target
$433 -> $440
2025-10-30
maintain
Outperform
Reason
Bernstein analyst Lance Wilkes raised the firm's price target on UnitedHealth to $440 from $433 and keeps an Outperform rating on the shares. The firm has updated its UnitedHealth EPS model post-Q3 earnings. Bernstein expects a sector-wide turnaround as MA and Medicaid recover from trough margins following MA rate shocks, withdrawal of competition, and redeterminations. The firm sees evidence that pricing discipline is being restored in MA and Optum Health, which will shock growth in the short-term but restore margin more swiftly. Bernstein sees UnitedHealth's valuation as attractive given its expectation for outsized EPS growth recovery over the next 4 years.
BofA
Neutral
maintain
$390 -> $410
2025-10-29
Reason
BofA
Price Target
$390 -> $410
2025-10-29
maintain
Neutral
Reason
BofA raised the firm's price target on UnitedHealth to $410 from $390 and keeps a Neutral rating on the shares. Q3 was "a little surprising" in that UHC margins outperformed while Optum Health and Insight both came in below expectations, the analyst tells investors. The "good news" is that UnitedHealth was able to handle the incremental investment and raised guidance by 25c, giving the firm more confidence that "it gave itself plenty of cushion" in its Q2 guidance reset, adds the analyst, who also raised the firm's estimates to reflect updated guidance.
Oppenheimer
Oppenheimer
Outperform
maintain
$325 -> $415
2025-10-29
Reason
Oppenheimer
Oppenheimer
Price Target
$325 -> $415
2025-10-29
maintain
Outperform
Reason
Oppenheimer raised the firm's price target on UnitedHealth to $415 from $325 and keeps an Outperform rating on the shares. The firm notes the company produced solid Q3 results, raising its outlook and reiterating most long-term targets. For MA, the outlook remains on track with prior comments, with 2026 margins expected to improve in 2026 and then return to the top-end of its 2%-4% target range by 2027. Meanwhile, OptumHealth expects margin improvement in 2026 as it rebounds toward long-term target margins of 6%-8%, Oppenheimer adds. Overall, the firm believes these results were a first positive step for UnitedHealth, which is setting more realistic goals as it looks to re-establish credibility with the Street.
RBC Capital
Ben Hendrix
Outperform
maintain
$286 -> $408
2025-10-29
Reason
RBC Capital
Ben Hendrix
Price Target
$286 -> $408
2025-10-29
maintain
Outperform
Reason
RBC Capital analyst Ben Hendrix raised the firm's price target on UnitedHealth to $408 from $286 and keeps an Outperform rating on the shares after its Q3 earnings beat. The management voiced confidence in pricing actions and plan exits driving margin expansion across the enterprise next year, the analyst tells investors in a research note. With expectations of margin improvement accelerating in 2027, UnitedHealth should see EPS growth near the low-end of its long-term annual EPS growth target of 13%-16%, the firm added.
UBS
Buy
maintain
$378 -> $430
2025-10-29
Reason
UBS
Price Target
$378 -> $430
2025-10-29
maintain
Buy
Reason
UBS raised the firm's price target on UnitedHealth to $430 from $378 and keeps a Buy rating on the shares. UnitedHealth sounded more confident on the growth trajectory for 2027 and beyond, the analyst tells investors in a research note.
See All Ratings

Valuation Metrics

The current forward P/E ratio for UnitedHealth Group Inc (UNH.N) is 19.49, compared to its 5-year average forward P/E of 20.65. For a more detailed relative valuation and DCF analysis to assess UnitedHealth Group Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
20.65
Current PE
19.49
Overvalued PE
23.85
Undervalued PE
17.45

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average EV/EBITDA
14.49
Current EV/EBITDA
13.17
Overvalued EV/EBITDA
16.39
Undervalued EV/EBITDA
12.59

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.89
Current PS
327.45
Overvalued PS
33.69
Undervalued PS
-25.91
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

UNH News & Events

Events Timeline

(ET)
2025-11-12
14:16:54
Positive momentum for UnitedHealth as shares rise 3.73%
select
2025-11-12
09:55:01
Significant Early Gainers in Liquid Options on November 12th
select
2025-11-11 (ET)
2025-11-11
11:19:33
UnitedHealth Shares Dip 0.34% Amid Mixed Sentiment on Options
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
11-10Yahoo Finance
PinnedWhat Transpired with UnitedHealth (UNH)
  • Pelican Bay Capital Management Performance: In its third-quarter 2025 investor letter, Pelican Bay Capital Management's Concentrated Value Strategy achieved a 7.8% return, outperforming the Russell 1000 Value Index's 5.3% return for the same period.

  • UnitedHealth Group's Financial Overview: UnitedHealth Group Incorporated reported a one-month return of -9.61% and a 52-week loss of 48.15%, with a market capitalization of $293.682 billion as of November 7, 2025.

  • Challenges in the Health Insurance Sector: The investor letter highlighted pressures in the health insurance industry, particularly for UnitedHealth Group, due to aggressive pricing from competitors and increased utilization of healthcare services.

  • Investment Outlook: While acknowledging UnitedHealth Group's potential, Pelican Bay Capital Management suggested that certain AI stocks may offer better upside potential and lower downside risk compared to the healthcare giant.

[object Object]
Preview
9.5
11-10NASDAQ.COM
Pinned"With Upgraded Guidance and Strong Q3 Performance, Could UnitedHealth Stock Experience a Surge?"
  • Earnings Performance: UnitedHealth reported a revenue increase of 12% year-over-year, totaling $113.2 billion, but its earnings from operations fell to $4.3 billion, half of the previous year's figure. The adjusted earnings per share of $2.92 exceeded analyst expectations.

  • Stock Valuation and Market Position: Despite a recent rally, UnitedHealth's stock is down nearly 50% from its 52-week high and trades at a forward P/E of 20, slightly below the S&P 500 average of 22, indicating a potential value opportunity for investors.

  • Challenges Ahead: The company faces ongoing investigations into its billing practices, which could impact its valuation and recovery, despite recent positive earnings news and an increase in guidance for the year.

  • Long-term Outlook: While short-term headwinds persist, long-term investors may find UnitedHealth a worthwhile investment due to its modest valuation and potential for recovery, as indicated by interest from notable investors like Warren Buffett.

[object Object]
Preview
4.5
05:54 AMWSJ
Dow Surges Past 48,000 as Tech Stocks Lag Behind
  • Investor Optimism: Anticipation of an end to the U.S. government shutdown drove the Dow Jones Industrial Average above 48,000 for the first time.

  • Sector Performance: The expected resolution of the shutdown positively impacted large banks, airline companies, and consumer products makers, while technology stocks continued to show weakness.

  • Economic Activity Boost: The potential lifting of air travel restrictions and the resumption of government employee pay are expected to enhance economic activity.

  • Market Contrast: The rise in the Dow contrasts with the ongoing struggles faced by technology stocks amidst the broader market optimism.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is UnitedHealth Group Inc (UNH) stock price today?

The current price of UNH is 339.06 USD — it has increased 3.55 % in the last trading day.

arrow icon

What is UnitedHealth Group Inc (UNH)'s business?

UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health offers comprehensive and patient-centered care, addressing the physical, mental, social, and financial well-being. Optum Health delivers primary, specialty and surgical care; helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.

arrow icon

What is the price predicton of UNH Stock?

Wall Street analysts forecast UNH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UNH is 386.27 USD with a low forecast of 198.00 USD and a high forecast of 440.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is UnitedHealth Group Inc (UNH)'s revenue for the last quarter?

UnitedHealth Group Inc revenue for the last quarter amounts to 113.16B USD, increased 12.24 % YoY.

arrow icon

What is UnitedHealth Group Inc (UNH)'s earnings per share (EPS) for the last quarter?

UnitedHealth Group Inc. EPS for the last quarter amounts to 2.59 USD, decreased -60.22 % YoY.

arrow icon

What changes have occurred in the market's expectations for UnitedHealth Group Inc (UNH)'s fundamentals?

The market is revising Downward the revenue expectations for UnitedHealth Group Incorporated (UNH) for FY2025, with the revenue forecasts being adjusted by -0.16% over the past three months. During the same period, the stock price has changed by 29.62%.
arrow icon

How many employees does UnitedHealth Group Inc (UNH). have?

UnitedHealth Group Inc (UNH) has 400000 emplpoyees as of November 13 2025.

arrow icon

What is UnitedHealth Group Inc (UNH) market cap?

Today UNH has the market capitalization of 307.13B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto Tracker
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free